Skip to content

Evaluation of the effect of using hotshot in children undergoing open heart surgery

Evaluation of the effect of using hotshot in children undergoing open-heart surgery on arrhythmia control and the need for inotropes at the time of weaning from the Cardiopulmonary bypass

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210526051408N1
Enrollment
100
Registered
2021-10-02
Start date
2021-08-23
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open heart surgery. Cardiac arrhythmia, unspecified

Interventions

Intervention 1: Intervention group: In the hot-shot group (intervention), warmblood with a temperature of 37 degrees was used for patients. Hot-shot Immediately before removing the aortic cross-clamp

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 6 Years

Inclusion criteria

Inclusion criteria: Children one month to six years old are candidates for open heart surgery using Cardiopulmonary bypass Written consent of the patient to participate in study Normal status of coagulation tests Left ventricular ejection fraction greater than 30% Patients with levels one and two based on the risk factor for congenital heart surgery (RACHS) score

Exclusion criteria

Exclusion criteria: Patients who open heart surgery is concurrent with other noncardiac surgery History of cardiac surgery History of preoperative arrhythmia Critical patients with severe underlying disease Patient with anemia

Design outcomes

Primary

MeasureTime frame
Need for inotropic drugs. Timepoint: Before, during and after the operation. Method of measurement: The infused inotropic agents based on inotropic score.;Arrhythmia incidence. Timepoint: Before, during and after the operation. Method of measurement: Electrocardiographic monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahmood Hosseinzadeh Maleki

Mashhad University of Medical Sciences

mahmoodhosseinzadeh@yahoo.com+98 51 3854 3031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026